ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1483

Down-regulation of Hematopoietic Progenitor Kinase 1 by Aberrant Epigenetic Alterations in T Follicular Helper Cells Accounts for Excessive Immunity in Systemic Lupus Erythematosus

Qing Zhang1, Huilin Zhang2 and Yuming Xie1, 1Department of Dermatology, Second Xiangya Hospital, Central South University, Changsha, China (People's Republic), 2Clinical Nursing Teaching and Research Section, Second Xiangya Hospital, Central South University, Changsha, China (People's Republic)

Meeting: ACR Convergence 2021

Keywords: DNA Methylation, histone methylation, HPK1, Systemic lupus erythematosus (SLE), Tfh cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: SLE – Etiology & Pathogenesis Poster (1480–1506)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: Recently, T follicular helper cells (Tfh cells) have been discovered to be the main CD4+ T cells assisting B cells to produce antibody. Tfh cells are over activated in patients with systemic lupus erythematosus (SLE), consequently lead to excessive immunity. Hematopoietic progenitor kinase 1 (HPK1) negatively regulates T cell-mediated immune responses and TCR signal. This study aims to investigate the roles of HPK1 and the mechanisms that regulate HPK1 expression in SLE Tfh cells.

Methods: Naive CD4+ T cells and B cells were isolated from 30 normal controls and 30 SLE patients. Subsequently naive CD4+ T cells were induced to differentiate into Tfh cells by culturing with anti-CD3 antibody, anti-CD28 antibody, IL-6, IL-12, IL-21, and TGF-β. HPK1 mRNA and protein levels in Tfh cells were measured by quantitative PCR (qPCR) and western blot analysis respectively. The productions of IL-21, BAFF, IFNγ, IL-17A, IgM, IgG1, IgG2, and IgG3 were analyzed using ELISA. Tfh cells proliferation was evaluated with MTT assay. Numbers of histone H3 lysine 27 trimethylation (H3K27me3), H3K27 methyltransferase enhancer of zeste homolog 2 (EZH2), H3K27 demethylase jumonji domain containing 3 (JMJD3), and DNA methyltransferase 3a (DNMT3a) within the HPK1 promoter were determined by chromatin immunoprecipitation (ChIP) combined with qPCR. DNA methylation abundance at the HPK1 promoter was assessed by methylated DNA immunoprecipitation (MeDIP) combined with qPCR.

Results: HPK1 mRNA and protein levels were significantly reduced in SLE Tfh cells, and HPK1 mRNA level negatively correlated with SLE Disease Activity Index (SLEDAI). Knocking down HPK1 with siRNA in normal Tfh cells significantly elevated Tfh cells proliferation and secretions of IL-21, BAFF, IFNγ, IgG1, IgG2, and IgG3. There were no marked alters in IL-17A and IgM productions. The opposite effects were observed in SLE Tfh cells transfected with HPK1 overexpressing plasmid: Tfh cells proliferation and productions of IL-21, BAFF, IFNγ, IgG1, IgG2, and IgG3 were all alleviated. And there were no significant changes in IL-17A and IgM levels. H3K27me3, DNA methylation, and DNMT3a amounts sharply increased at the HPK1 promoter in SLE Tfh cells compared to controls. Moreover, a striking decrease was detected in JMJD3 enrichment, but no marked change in EZH2 number at the HPK1 promoter of Tfh cells from patients with SLE.

Conclusion: Our results suggest for the first time that at the HPK1 promote region of SLE Tfh cells, decreased JMJD3 binding up-regulates H3K27me3 amount, and increased DNMT3a enrichment elevates DNA methylation level. All these factors inhibit expression of HPK1 in SLE Tfh cells, leading to Tfh cells overactivation and B cells overstimulation, subsequently, the onset and progression of SLE.


Disclosures: Q. Zhang, None; H. Zhang, None; Y. Xie, None.

To cite this abstract in AMA style:

Zhang Q, Zhang H, Xie Y. Down-regulation of Hematopoietic Progenitor Kinase 1 by Aberrant Epigenetic Alterations in T Follicular Helper Cells Accounts for Excessive Immunity in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/down-regulation-of-hematopoietic-progenitor-kinase-1-by-aberrant-epigenetic-alterations-in-t-follicular-helper-cells-accounts-for-excessive-immunity-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/down-regulation-of-hematopoietic-progenitor-kinase-1-by-aberrant-epigenetic-alterations-in-t-follicular-helper-cells-accounts-for-excessive-immunity-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology